Development of a novel proteomic approach for the detection of transitional cell carcinoma of the bladder in urine
about
Upregulated expression of human neutrophil peptides 1, 2 and 3 (HNP 1-3) in colon cancer serum and tumours: a biomarker studyDiagnosis of Ovarian Cancer Using Decision Tree Classification of Mass Spectral DataPostgenomics: Proteomics and Bioinformatics in Cancer ResearchA data review and re-assessment of ovarian cancer serum proteomic profilingApplication of serum SELDI proteomic patterns in diagnosis of lung cancerBiomarkers for non-muscle invasive bladder cancer: Current tests and future promiseWhat are the currently available and in development molecular markers for bladder cancer? Will they prove to be useful in the future?A review of novel analytical diagnostics for liquid biopsies: spectroscopic and spectrometric serum profiling of primary and secondary brain tumorsDiscovery and validation of urinary biomarkers for prostate cancerGastric cancer-specific protein profile identified using endoscopic biopsy samples via MALDI mass spectrometry.Identification of markers of taxane sensitivity using proteomic and genomic analyses of breast tumors from patients receiving neoadjuvant paclitaxel and radiation.Proteomic profiling of cholangiocarcinoma: diagnostic potential of SELDI-TOF MS in malignant bile duct stricture.DNA affinity capture and protein profiling by SELDI-TOF mass spectrometry: effect of DNA methylationSurface-enhanced laser desorption/ionization time-of-flight mass spectrometry: serum protein profiling in seminoma patients.Identification of biomarkers for ovarian cancer using strong anion-exchange ProteinChips: potential use in diagnosis and prognosis.Pharmacoproteomic analysis of prechemotherapy and postchemotherapy plasma samples from patients receiving neoadjuvant or adjuvant chemotherapy for breast carcinoma.Diagnosis of gastric cancer using decision tree classification of mass spectral data.Detection of bladder cancer using proteomic profiling of urine sedimentsProfiling of acyl-CoA oxidase-deficient and peroxisome proliferator Wy14,643-treated mouse liver protein by surface-enhanced laser desorption/ionization ProteinChip Biology System.Tagless extraction-retentate chromatography: a new global protein digestion strategy for monitoring differential protein expression.An integrated approach to the detection of colorectal cancer utilizing proteomics and bioinformatics.Understanding cancer through proteomics.Serum, salivary and tissue proteomics for discovery of biomarkers for head and neck cancers.SELDI-TOF MS profiling of serum for detection of the progression of chronic hepatitis C to hepatocellular carcinoma.Identification of hemoglobin-alpha and -beta subunits as potential serum biomarkers for the diagnosis and prognosis of ovarian cancer.Cytologic findings and protein expression profiles associated with ductal carcinoma of the breast in ductal lavage specimens using surface-enhanced laser desorption and ionization-time of flight mass spectrometry.Evaluation of matrix-assisted laser desorption/ionization-time of flight mass spectrometry proteomic profiling: identification of alpha 2-HS glycoprotein B-chain as a biomarker of diet.Discrete serum protein signatures discriminate between human retrovirus-associated hematologic and neurologic disease.Application of SELDI-TOF mass spectrometry for the identification of differentially expressed proteins in transformed follicular lymphoma.Protein profiling of urine from dogs with renal disease using ProteinChip analysis.A strategy for high-resolution protein identification in surface-enhanced laser desorption/ionization mass spectrometry: calgranulin A and chaperonin 10 as protein markers for endometrial carcinoma.Prediction of pancreatic cancer by serum biomarkers using surface-enhanced laser desorption/ionization-based decision tree classification.Elevated levels of human alpha -defensin in tears of patients with allergic conjunctival disease complicated by corneal lesions: detection by SELDI ProteinChip system and quantification.Proteohistography--direct analysis of tissue with high sensitivity and high spatial resolution using ProteinChip technology.Mass spectrometry in diagnostic oncoproteomics.Differential detection of S100A8 in transitional cell carcinoma of the bladder by pair wise tissue proteomic and immunohistochemical analysis.Proteomic profiling in the sera of workers occupationally exposed to arsenic and lead: identification of potential biomarkers.Detection and identification of heat shock protein 10 as a biomarker in colorectal cancer by protein profiling.Identification of complement C3a as a candidate biomarker in human chronic hepatitis C and HCV-related hepatocellular carcinoma using a proteomics approach.Protein profiling of organic stone matrix and urine from dogs with urolithiasis.
P2860
Q21260439-68CC80AA-270E-48F7-B731-632345FEFC97Q24798791-1349D196-6690-474D-B976-7FAAE276DE8FQ24800450-3DE1A281-D5ED-4F89-A591-A2FD01012F4CQ24806513-6A98AC6F-8EB8-4709-941F-4EF844C019E3Q24810545-829DCDC1-8B98-4DE8-B1B6-5A98693BBA8DQ26775990-49C90F02-C563-4820-B767-C964EA9B01E0Q26795518-D0E4D4B6-EB22-4509-BCE3-92BC9D4F52AAQ28069912-83364689-2F77-45B6-AFF4-CE02D94CF386Q30438582-0BF53B51-2C3A-488C-ACC1-3EEDC14F3093Q30463611-008120E8-88D2-4D83-A44C-45B81D3A27EFQ30477571-341C0F20-5D56-4D46-B205-5EB6C3440D8AQ30823098-675A4A91-939D-4A50-A846-94E5C92F2B7EQ30838522-B94DFBDF-F4E7-49A6-BC8D-B623FBE4CD59Q30865540-8AA90016-6361-4ED2-AA71-890B1DBB4787Q31005059-82B8AE38-97DD-4580-9E20-D41EA3469DBDQ31052724-FA1D0E5B-C3C2-4C97-9748-241FEB35AA6DQ31068299-ED4BE373-2BF9-45A8-8E66-6965062C383BQ31083527-080A5801-FD3C-46A1-A01E-9F29D08FD927Q31103503-FA9AC96C-21A0-436D-8944-514745D7D4B5Q31111488-CAA7AB43-C242-4A8A-B922-9FCC49741E60Q31117651-0D0FA8A6-7726-43B1-9F27-98BC9FF0578BQ31134537-6CE71830-5960-4777-96D5-2532480BD45BQ31148835-8A53D4BE-7A1A-4484-B7A3-F89EDA72621AQ31149403-C9DD0B98-084D-4BA8-AE62-BB416FF1A787Q31154011-23E87D07-DA0C-4B95-BAB8-5AF3DA2078B4Q31158896-9400EBFB-A7C0-4F27-9D43-6EC7FC14EACAQ31161497-6388CF7E-96AD-4179-B5E3-7AC29FC899FFQ31172613-2F5010D3-D890-4504-AA0B-48D41134C83AQ33201992-B5325E4D-9061-4C93-BB17-42B9B40EC9B9Q33205784-178EDBEE-BC9E-4ABD-A6BB-61CB51288F40Q33213824-18C0D77F-FBBB-4B5E-B24C-0216E81D946EQ33214577-22D94547-A13D-4F36-90ED-E860EB5FAA4DQ33222290-640A2D23-A803-493D-BE03-6B454A8BC47BQ33222950-ACDBA32E-0B4D-4BCE-A481-4FD19F2AEAC4Q33224210-BDDFF490-A920-45E7-B6B3-646DA6CD1693Q33226038-948C4912-BF09-4B95-9C88-83E3DEDBE145Q33230657-24BB9F56-EE5A-469C-A0E5-D59F7C21B16BQ33234789-B15D7311-4562-4FE4-B305-5B2BE3CD9F9CQ33238625-85E541D0-63F7-4D6F-B0C4-E3B6394FFA7FQ33242872-87E411B6-8CA3-493B-800C-26BDFF947CC3
P2860
Development of a novel proteomic approach for the detection of transitional cell carcinoma of the bladder in urine
description
2001 nî lūn-bûn
@nan
2001 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Development of a novel proteom ...... cinoma of the bladder in urine
@ast
Development of a novel proteom ...... cinoma of the bladder in urine
@en
type
label
Development of a novel proteom ...... cinoma of the bladder in urine
@ast
Development of a novel proteom ...... cinoma of the bladder in urine
@en
prefLabel
Development of a novel proteom ...... cinoma of the bladder in urine
@ast
Development of a novel proteom ...... cinoma of the bladder in urine
@en
P2093
P2860
P1476
Development of a novel proteom ...... cinoma of the bladder in urine
@en
P2093
F I Kondylis
G L Wright Jr
P F Schellhammer
S Mendrinos
P2860
P304
P356
10.1016/S0002-9440(10)64100-4
P407
P577
2001-04-01T00:00:00Z